Body mass index and risk of cardiovascular disease, cancer and all-cause mortality.

Pennington Biomedical Research Center, Baton Rouge, LA 70808-4124, USA.
Canadian journal of public health. Revue canadienne de santé publique (Impact Factor: 1.02). 01/2011; 103(2):147-51.
Source: PubMed

ABSTRACT To determine the dose-response relationship between body mass index (BMI) and cause-specific mortality among Canadian adults.
The sample includes 10,522 adults 18-74 years of age who participated in the Canadian Heart Health Surveys (1986-1995). Participants were divided into 5 BMI categories (< 18.5, 18.5-24.9, 25-29.9, 30-34.9, and > or = 35 kg/m2). Multivariate-adjusted (age, sex, exam year, smoking status, alcohol consumption and education) hazard ratios for all-cause, cardiovascular disease (CVD) and cancer mortality were estimated using Cox proportional hazards regression.
There were 1,149 deaths (402 CVD; 412 cancer) over an average of 13.9 years (range 0.5 to 19.1 years), and the analyses are based on 145,865 person-years. The hazard ratios (95% CI) across successive BMI categories for all-cause mortality were 1.25 (0.83-1.90), 1.00 (reference), 1.06 (0.92-1.22), 1.27 (1.07-1.51) and 1.65 (1.29-2.10). The corresponding hazard ratios for CVD mortality were 1.30 (0.60-2.83), 1.00 (reference), 1.57 (1.22-2.01), 1.72 (1.27-2.33) and 2.09 (1.35-3.22); and for cancer, the hazard ratios were 1.02 (0.48-2.21), 1.00 (reference), 1.14 (0.90-1.44), 1.34 (1.01-1.78) and 1.82 (1.22-2.71). There were significant linear trends across BMI categories for all-cause (p = 0.0001), CVD (p < 0.0001) and cancer mortality (p = 0.003).
The results demonstrate significant relationships between BMI and mortality from all causes, CVD and cancer. The increased risk of all-cause, CVD and cancer mortality associated with an elevated BMI was significant at levels above 30 kg/m2; however, overweight individuals (BMI 25-29.9 kg/m2) also had an approximately 60% higher risk of CVD mortality.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective We aimed to systematically compare patients with major depressive disorder (MDD) from three different treatment settings (a primary care outpatient, a secondary care outpatient and one inpatient sample), with regard to metabolic syndrome (MetSyn) prevalences, individual MetSyn components and related metabolic variables. Method The outpatient samples were drawn from the ongoing Netherlands Study of Depression and Anxiety (NESDA; 302 primary care and 445 secondary care outpatients). The inpatient sample (n = 80) was recruited from five Dutch mental health hospitals. The assessments of MetSyn and related variables (waist circumference (WC), high-density and low-density lipoprotein cholesterol (HDL), triglycerides, glucose, and systolic and diastolic blood pressure (SBP, DBP), body mass index (BMI), waist hip ratio (WHR), low-density lipoprotein and total cholesterol (LDL, TC)) were compared using analysis of (co)variance and regression analysis, whereas medication analyses examined the extent to which clinical differences (e.g. depression severity or medication use) mediated the observed metabolic differences across setting. Results MetSyn prevalences (26% primary, 24% secondary care and 28% inpatients) did not significantly differ (P = .71). WC, BMI, LDL cholesterol, glucose and DBP were not significantly different across settings. However, WHR, total cholesterol and triglyceride levels were higher in inpatients than in both outpatients groups, while HDL cholesterol levels and SBP were lower. There was some mediating role for tricyclic and non-SSRI antidepressant use, but overall the mediating role of clinical differences was limited. Conclusions Although overall MetSyn prevalences did not differ, patterns of individual MetSyn-related variables differed more markedly across depressed inpatients and outpatients. Inpatients showed more adverse WHR and serum lipid profiles, while systolic blood pressure levels were lower.
    General Hospital Psychiatry 09/2014; 36(5). DOI:10.1016/j.genhosppsych.2014.05.018 · 2.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Projection analyses can provide estimates of the future health burden of increasing BMI and represent a relevant and useful tool for public health planning. Our study presents long-term (2013-2030) projections of the prevalence and numbers of individuals by BMI category for adult men and women in Quebec. Three applications of projections to estimate outcomes more directly pertinent to public health planning as well as an in-depth discussion of limits are provided with the aim of encouraging greater use of projection analyses by public health officers.
    BMC Public Health 09/2014; 14(1):996. DOI:10.1186/1471-2458-14-996 · 2.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Body mass index (BMI) is a strong predictor of mortality in the general population. In spite of the medical hazards of obesity, a protective effect on mortality has been suggested in surgical patients: the obesity paradox. The aim of the present nationwide cohort study was to examine the association between BMI and mortality in patients treated surgically for perforated peptic ulcer (PPU).Methods This was a national prospective cohort study of all Danish patients treated surgically for PPU between 1 February 2003 and 31 August 2009, for whom BMI was registered. Non-surgically treated patients and those with malignant ulcers were excluded. The primary outcome measure was 90-day mortality. The association between BMI and mortality was calculated as crude and adjusted relative risks (RRs) with 95 per cent confidence intervals (c.i.).ResultsOf 2668 patients who underwent surgical treatment for PPU, 1699 (63·7 per cent) had BMI recorded. Median age was 69·4 (range 17·6–100·9) years and 53·7 per cent of the patients were women. Some 1126 patients (66·3 per cent) had at least one of six co-morbid diseases; 728 (42·8 per cent) had an American Society of Anesthesiologists grade of III or more. A total of 471 patients (27·7 per cent) died within 90 days of surgery. Being underweight was associated with a more than twofold increased risk of death following surgery for PPU (adjusted RR 2·26, 95 per cent c.i. 1·37 to 3·71). No statistically significant association was found between obesity and mortality.Conclusion Being underweight was associated with increased mortality in patients with PPU, whereas being overweight or obese was neither protective nor an adverse prognostic factor.
    British Journal of Surgery 07/2014; 101(8). DOI:10.1002/bjs.9529 · 5.21 Impact Factor

Full-text (2 Sources)

Available from
Apr 13, 2015